SecBot SecBot
144 ·Filed Nov 9, 2026

CYTK

CYTOKINETICS INC
NEUTRAL
Impact 2/10
Horizondays Processed7d 6h ago SEC0001950047-26-010860
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small relative to market cap and conducted under a pre-arranged 10b5-1 plan, reducing the likelihood of opportunistic insider selling. Monitor the company's upcoming earnings and any changes in insider trading patterns for further signals.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$56.18
T+0 close · Nov 9, 2026 · via day close
Latest settled
+4.18%
T+1 · $58.53
Vs SPY
+2.86%
α at T+1
Next horizon
T+5
in 8h
  1. T+0 · Nov 10 $56.18entry
  2. T+1 · 6d ago +4.18%α +2.86% · $58.53
  3. T+4 · todayOpen
  4. T+5 · in 8h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director B. Lynne Parshall filed a Form 144 notice of intent to sell 5,000 shares of Cytokinetics common stock, with an estimated aggregate market value of $268,450. The shares were acquired via restricted stock units vested on May 14, 2026. The sale is planned for execution on or after November 9, 2026, and is part of a 10b5-1 trading plan established on September 1, 2026.

Key Facts

  • Director B. Lynne Parshall intends to sell 5,000 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $268,450.
  • Shares were acquired via restricted stock units that vested on May 14, 2026.
  • The sale is planned for execution on or after November 9, 2026.
  • The sale is conducted under a 10b5-1 trading plan established on September 1, 2026.
  • The filing is an advance notice of intent to sell, not a completed transaction.

Financial Impact

Proposed sale of 5,000 shares valued at approximately $268,450, representing about 0.0036% of the company's $7.7B market cap.

dilution

Risk Factors

  • The sale may not be completed; Form 144 is only an intent to sell.
  • Director-level sales, even small ones, can sometimes signal reduced conviction, though the 10b5-1 plan mitigates this concern.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (28 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010860
Document: 0001950047-26-010860-index.html0001950047-26-010860
Document: 0001950047-26-010860.txt0001950047-26-010860

Track record

46 reports on CYTK

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $53.17 −1.10% settles Dec 15
  2. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $53.17 −5.27% settles Dec 14
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
  4. Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $56.18 Now $53.17 −5.36% settles Dec 9
  5. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
  6. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
  7. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  8. Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $53.17 −4.28% settles Dec 4
  9. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $63.60 Now $53.17 −16.40% settles Dec 3
  10. Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $53.17 −14.28% settles Dec 1
Showing 10 of 46

US Market Status

Market Closed · Opens Wed (10h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026